{ "cik": 1649904, "cik_padded": "0001649904", "entityName": "RHYTHM PHARMACEUTICALS, INC.", "fiscal_years": [ { "accn": "0001628280-26-012399", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 953000.0, "cash": 54301000.0, "eps_diluted": -3.11, "free_cash_flow": -116628000.0, "net_income": -196539000.0, "operating_cash_flow": -115675000.0, "operating_income": -192016000.0, "revenue": 189757000.0, "stockholders_equity": 139069000.0, "total_assets": 480196000.0, "total_liabilities": 210170000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.5112641925950427, "net_margin": -1.0357404469927327, "operating_margin": -1.011904699167883, "revenue_growth_yoy": 0.4582558443354902, "roa_avg2y": -0.45053520526230734, "roa_period_end": -0.40928912360786013, "roe_avg2y": -2.444545330165798, "roe_period_end": -1.413248099864096 } }, { "accn": "0001628280-26-012399", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 89137000.0, "eps_diluted": -4.34, "free_cash_flow": -113879000.0, "net_income": -260602000.0, "operating_cash_flow": -113879000.0, "operating_income": -265503000.0, "revenue": 130126000.0, "stockholders_equity": 21729000.0, "total_assets": 392273000.0, "total_liabilities": 227724000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 10.480187767499654, "revenue_growth_yoy": 0.6806064989409516, "roa_avg2y": -0.7188842208055524, "roa_period_end": -0.6643383561958126, "roe_avg2y": -2.72186246657754 } }, { "accn": "0001628280-26-012399", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 47000.0, "cash": 60081000.0, "eps_diluted": -3.2, "free_cash_flow": -136204000.0, "net_income": -184678000.0, "operating_cash_flow": -136157000.0, "operating_income": -184357000.0, "revenue": 77428000.0, "stockholders_equity": 169759000.0, "total_assets": 332745000.0, "total_liabilities": 162986000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9601022626193604, "revenue_growth_yoy": 2.275573229545647, "roa_avg2y": -0.5164185865726357, "roa_period_end": -0.5550135990022389, "roe_avg2y": -0.8510095133645607, "roe_period_end": -1.087883411188803 } }, { "accn": "0001628280-26-012399", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 281000.0, "cash": 127677000.0, "eps_diluted": -3.47, "free_cash_flow": -173709000.0, "net_income": -181119000.0, "operating_cash_flow": -173428000.0, "operating_income": -179157000.0, "revenue": 23638000.0, "stockholders_equity": 264262000.0, "total_assets": 382481000.0, "total_liabilities": 118219000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.447355276203162, "revenue_growth_yoy": 6.494610019023463, "roa_avg2y": -0.5087583777619227, "roa_period_end": -0.47353724760184174, "roe_avg2y": -0.6605204471812302, "roe_period_end": -0.6853766337952486 } }, { "accn": "0001558370-25-001889", "filed": "2025-02-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 434000.0, "cash": 59248000.0, "eps_diluted": -1.4, "free_cash_flow": -146437000.0, "net_income": -69612000.0, "operating_cash_flow": -146003000.0, "operating_income": -170059000.0, "revenue": 3154000.0, "stockholders_equity": 284151000.0, "total_assets": 329523000.0, "total_liabilities": 45372000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1596756654032539, "roa_avg2y": -0.2695026674616141, "roa_period_end": -0.21125080798608897, "roe_avg2y": -0.30892053989646734, "roe_period_end": -0.24498242131824277 } }, { "accn": "0001558370-24-002181", "filed": "2024-02-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 214000.0, "cash": 100854000.0, "eps_diluted": -3.04, "free_cash_flow": -122194000.0, "net_income": -133996000.0, "operating_cash_flow": -121980000.0, "operating_income": -136575000.0, "stockholders_equity": 166528000.0, "total_assets": 187073000.0, "total_liabilities": 20545000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12337264604150654, "roa_avg2y": -0.5407468986836051, "roa_period_end": -0.7162765337595484, "roe_avg2y": -0.5988005755807199, "roe_period_end": -0.8046454650269024 } }, { "accn": "0001558370-23-002613", "filed": "2023-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3385000.0, "cash": 62294000.0, "eps_diluted": -3.86, "free_cash_flow": -126135000.0, "net_income": -140729000.0, "operating_cash_flow": -122750000.0, "operating_income": -146000000.0, "stockholders_equity": 281020000.0, "total_assets": 308523000.0, "total_liabilities": 27503000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.09786847911180699, "roa_avg2y": -0.4948860009881614, "roa_period_end": -0.45613779199605864, "roe_avg2y": -0.5337963419537396, "roe_period_end": -0.5007793039641306 } }, { "accn": "0001558370-22-002543", "filed": "2022-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 722000.0, "cash": 49542000.0, "free_cash_flow": -62778000.0, "net_income": -74064000.0, "operating_cash_flow": -62056000.0, "operating_income": -78417000.0, "stockholders_equity": 246256000.0, "total_assets": 260210000.0, "total_liabilities": 13954000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05666460918718732, "roa_avg2y": -0.35958111014550453, "roa_period_end": -0.28463164367241844, "roe_avg2y": -0.378801362506521, "roe_period_end": -0.3007601845234228 } }, { "accn": "0001558370-21-002121", "filed": "2021-03-01", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 133000.0, "cash": 34236000.0, "free_cash_flow": -29593000.0, "net_income": -33709000.0, "operating_cash_flow": -29460000.0, "operating_income": -32412000.0, "stockholders_equity": 144788000.0, "total_assets": 151736000.0, "total_liabilities": 6948000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.04798740227090643, "roa_avg2y": -0.4108974554319671, "roa_period_end": -0.22215558601782043, "roe_avg2y": -0.6014899406700273, "roe_period_end": -0.23281625549078652 } }, { "accn": "0001558370-20-001896", "filed": "2020-03-02", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1057000.0, "cash": 6540000.0, "free_cash_flow": -24276000.0, "operating_cash_flow": -23219000.0, "operating_income": -25905000.0, "stockholders_equity": -32703000.0, "total_assets": 12339000.0, "total_liabilities": 5042000.0 }, "period_end": "2016-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-012399", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001649904.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001649904.json" }, "ticker": "RYTM" }